The Enterprise Value as of December 2025 (TTM) for P3 Health Partners Inc. (PIIIW) is 29.91M

According to P3 Health Partners Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 29.91M. This represents a change of -78.26% compared to the average of 137.59M of the last 4 quarters.

P3 Health Partners Inc. (PIIIW) Historical Enterprise Value (quarterly & annually)

How has PIIIW Enterprise Value performed in the past?

The mean historical Enterprise Value of P3 Health Partners Inc. over the last ten years is 198.77M. The current 29.91M Enterprise Value has changed 1.40% with respect to the historical average. Over the past ten years (40 quarters), PIIIW's Enterprise Value was at its highest in in the September 2021 quarter at 459.55M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

P3 Health Partners Inc. (PIIIW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of P3 Health Partners Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

P3 Health Partners Inc. (PIIIW) Average Enterprise Value

How has PIIIW Enterprise Value performed in the past?

The current Enterprise Value of P3 Health Partners Inc. (PIIIW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

P3 Health Partners Inc. (PIIIW) Enterprise Value vs. Peers

How is PIIIW’s Enterprise Value compared to its peers?

P3 Health Partners Inc.’s Enterprise Value is greater than Aclarion, Inc. (-9079187.00), greater than Vincerx Pharma, Inc. (-4374189.00), greater than Virpax Pharmaceuticals, Inc. (-1486964.00), greater than FOXO Technologies Inc. (9.43M), greater than Revelation Biosciences, Inc. (-6547388.00), greater than Silexion Therapeutics Ltd. (1.78M), greater than Dermata Therapeutics, Inc. (-2864817.00), greater than NKGen Biotech, Inc. Common Stock (4.60M), greater than Syros Pharmaceuticals, Inc. (1.96M), greater than Purple Biotech Ltd. (-2454140.71),

Build a custom stock screener for P3 Health Partners Inc. (PIIIW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like P3 Health Partners Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

P3 Health Partners Inc. (PIIIW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like P3 Health Partners Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.